Results 181 to 190 of about 762,494 (319)

Sensory nerve action potentials and sensory perception in women with arthritis of the hand [PDF]

, 2012
Kristina M. Calder, Alison Martin, Jessica Lydiate, Joy C. MacDermid, Victoria Galea, Norma J. MacIntyre   +5 more
openalex   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Integrating drug effects on individual cardiac ionic currents and cardiac action potentials to understand nonclinical translation to clinical ECG changes. [PDF]

Front Pharmacol
Johannesen L, Abi-Gerges N, Sweat K, Roup A, Page G, Baron CA, Yu H, Wu WW.   +7 more
europepmc   +1 more source

Opto-electronic feedback control of membrane potential for real-time control of action potentials. [PDF]

Cell Rep Methods, 2023
Ördög B, De Coster T, Dekker SO, Bart CI, Zhang J, Boink GJJ, Bax WH, Deng S, den Ouden BL, de Vries AAF, Pijnappels DA.   +10 more
europepmc   +1 more source

Measurement of Insect Action Potentials by MOSFET electrodes : 3rd Report: Recording of Action Potential

, 2004
Yoshihiko Kuwana
openalex   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Modulation of cardiomyocyte contractility and action potentials with chemogenetic chloride currents. [PDF]

J Physiol
Sönmez M, Stüdemann T, Manthey C, Covic A, Shehata N, Im J, Schwarzova B, Rössinger J, Srikantharajah R, Shibamiya A, Schwedhelm E, Eschenhagen T, Christ T, Weinberger F.   +13 more
europepmc   +1 more source

Temporal disparity of action potentials triggered in axon initial segments and distal axons in the neocortex. [PDF]

Sci Adv, 2023
Rózsa M, Tóth M, Oláh G, Baka J, Lákovics R, Barzó P, Tamás G.   +6 more
europepmc   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Guillain-Barré Syndrome with Discharges Following Compound Muscle Action Potentials: A-waves, M Dispersion or After-Discharges? [PDF]

Noro Psikiyatr Ars
Baslo SA, Karaağaç N, Öge AE.
europepmc   +1 more source